BIOFORMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 390,399 | 349,591 | 394,656 | 350,982 | 389,499 | 406,011 | 283,822 | 369,288 |
| Profit before tax | 51,324 | 36,788 | 85,870 | 29,161 | 41,284 | 27,279 | 9,741 | 7,768 |
| Net profit | 43,404 | 31,056 | 72,649 | 24,284 | 34,340 | 22,930 | 7,728 | 6,379 |
| Equity | 167,049 | 140,105 | 164,754 | 106,432 | 105,772 | 81,642 | 65,370 | 67,749 |
| Liabilities | 55,161 | 48,460 | 62,042 | 49,889 | 45,469 | 46,681 | 70,478 | 98,117 |
| Non-current assets | 89,421 | 74,090 | 61,364 | 60,088 | 49,639 | 38,323 | 62,874 | 55,830 |
| Current assets | 131,728 | 114,071 | 164,453 | 95,445 | 100,041 | 88,454 | 70,877 | 107,108 |
| Total assets | 221,149 | 188,161 | 225,817 | 155,533 | 149,680 | 126,777 | 133,751 | 162,938 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 102,202 | 72,588 | 93,630 |
| Social insurance contributions | - | - | - | - | - | 14,196 | 17,496 | 21,731 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -16.9% | -10.5% | +12.9% | -11.1% | +11.0% | +4.2% | -30.1% | +30.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 19.6% | 16.5% | 32.2% | 15.6% | 22.9% | 18.1% | 5.8% | 3.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 26.0% | 22.2% | 44.1% | 22.8% | 32.5% | 28.1% | 11.8% | 9.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.1% | 8.9% | 18.4% | 6.9% | 8.8% | 5.6% | 2.7% | 1.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 13.1% | 10.5% | 21.8% | 8.3% | 10.6% | 6.7% | 3.4% | 2.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.6 | 1.1 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 91,859 | 87,398 | 98,664 | 87,746 | 97,375 | 101,503 | 59,752 | 73,858 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOFORMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-12-05 | 0.01 |
| 2021-10-26 | 2021-11-04 | 0.01 |
BIOFORMA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOFORMA, UAB (code 300628385) is a Private Limited Liability Company engaged in wholesale of other chemical products. In 2025, revenue reached €369.3K, up 30.1% year on year, although it remained 9.0% below the 2023 level. Net profit was €6.4K, compared with €7.7K in 2024 and €22.9K in 2023, showing a gradual decline in profitability. The net profit margin narrowed to 1.7% in 2025 from 2.7% in 2024 and 5.6% in 2023. The company stayed profitable throughout the period, but earnings softened faster than revenue. Total assets increased to €162.9K in 2025 from €133.8K in 2024 and €126.8K in 2023. Equity stood at €67.7K and liabilities at €98.1K, compared with €65.4K and €70.5K a year earlier. The equity ratio was 41.6%, debt-to-equity 1.45, and asset turnover 2.27x. ROE was 9.4% and ROA 3.9%. Revenue per employee was €73.9K, while profit per employee was €1.3K.